Abstract P3-07-25: Efficacy and Safety of Neoadjuvant Pertuzumab Biosimilar TQB2440, Trastuzumab and Docetaxel in HR Negative, HER2 Positive Breast Cancer: a Single-Arm Trial
Cancer Research（2023）
关键词
Neoadjuvant Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要